There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Elevance Health (ELV – Research Report), Abbott Labs (ABT – Research Report) and Chemed (CHE – Research Report) with bullish sentiments.
Elevance Health (ELV)
In a report released today, Kevin Fischbeck from Bank of America Securities maintained a Buy rating on Elevance Health, with a price target of $580.00. The company’s shares closed last Tuesday at $505.31, close to its 52-week high of $513.23.
According to TipRanks.com, Fischbeck is a 3-star analyst with an average return of
Elevance Health has an analyst consensus of Strong Buy, with a price target consensus of $567.75.
See the top stocks recommended by analysts >>
Abbott Labs (ABT)
Bank of America Securities analyst Travis Steed maintained a Buy rating on Abbott Labs yesterday and set a price target of $120.00. The company’s shares closed last Tuesday at $111.34.
According to TipRanks.com, Steed is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Abbott Labs with a $126.54 average price target, representing a 12.5% upside. In a report issued on February 9, Wells Fargo also maintained a Buy rating on the stock with a $133.00 price target.
Chemed (CHE)
In a report released today, Joanna Gajuk from Bank of America Securities reiterated a Buy rating on Chemed, with a price target of $680.00. The company’s shares closed last Tuesday at $571.74.
According to TipRanks.com, Gajuk is a 3-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Chemed with a $680.00 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ELV:
- Elevance Health Declares Quarterly Dividend for Shareholders
- Elevance Health (NYSE:ELV) Jumps after Exceeding Q4 Estimates
- Elevance Health reports Medical membership totaled ~47M at Dec. 31, 2023
- Elevance Health raises quarterly dividend 10.1% to $1.63 per share
- Elevance Health sees FY24 adjusted EPS ‘greater than’ $37.10, consensus $37.05
